Starts and runs small drug companies, such as Immunovant.
No change
Greenlight owns 2.2 million shares of Roivant, worth about $76 million. That’s $2 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
2,152,669
Jun 30
2,152,669
The numbers
Shares they own
2,152,669
Value on Jun 30, 2026
$76,182,956
about $76 million
Share of their money
1.9%
$2 of every $100 · 18th of 46
Price per share on Jun 30
$35.39
Kind
Shares
Also owned by
No other fund we follow
More about Roivant ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.